Bioanalytical Systems Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
10.25 M |
Public Float |
6.93 M |
Bioanalytical Systems Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.09 |
Market Cap |
$20.58 M |
Shares Outstanding |
10.29 M |
Public Float |
7.19 M |
Address |
2701 Kent Avenue West Lafayette Indiana 47906 United States |
Employees | - |
Website | http://www.basinc.com |
Updated | 07/08/2019 |
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. |